Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 19, 2013, Pages 7850-7855

  Fozzatti, Laura ^a   Kim, Dong Wook ^a   Park, Jeong Won ^a   Willingham, Mark C ^b   Hollenberg, Anthony N ^c   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Fertility defect; Growth retardation; Lipid metabolism

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MUTANT PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR INTERACTING PROTEIN 140; THYROID HORMONE RECEPTOR ALPHA;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MALFORMATION; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GROWTH RETARDATION; HORMONE RECEPTOR INTERACTION; HYPOPHYSIS THYROID SYSTEM; IN VIVO STUDY; INFERTILITY; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR DOWN REGULATION;

FERTILITY DEFECT; GROWTH RETARDATION; LIPID METABOLISM;

ALLELES; ANIMALS; BONE DEVELOPMENT; CROSSES, GENETIC; FEMALE; FRAMESHIFT MUTATION; HYPOTHYROIDISM; INFERTILITY; LIPID METABOLISM; MALE; MICE; MUTATION; NUCLEAR RECEPTOR CO-REPRESSOR 1; PITUITARY GLAND; PROTEIN INTERACTION DOMAINS AND MOTIFS; THYROID GLAND; THYROID HORMONE RECEPTORS ALPHA; THYROXINE; TRIIODOTHYRONINE;

EID: 84877324732     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222334110     Document Type: Article

References (28)

1. Cheng SY (2000) Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 1(1-2): 9-18.
2. Johnson AB, O'Malley BW (2012) Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol Cell Endocrinol 348(2): 430-439.
3. Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14(3): 348-399.
4. Kaneshige M, et al. (2000) Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 97(24): 13209-13214.
5. Cheng SY (2004) New developments in thyroid hormone resistance. Hot Thyroidology No. 1.
6. Kaneshige M, et al. (2001) A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci USA 98(26): 15095-15100.
7. Liu YY, Schultz JJ, Brent GA (2003) A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem 278(40): 38913-38920.
8. Hashimoto K, et al. (2001) An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 98(7): 3998-4003.
9. Tinnikov A, et al. (2002) Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. EMBO J 21(19): 5079-5087.
10. Bochukova E, et al. (2012) A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 366(3): 243-249.
11. van Mullem A, et al. (2012) Clinical phenotype and mutant TRα1. N Engl J Med 366(15): 1451-1453.
12. Astapova I, et al. (2011) The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis. Mol Endocrinol 25(2): 212-224.
13. Astapova I, et al. (2008) The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proc Natl Acad Sci USA 105(49): 19544-19549.
14. Fozzatti L, et al. (2011) Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1). Proc Natl Acad Sci USA 108(42): 17462-17467.
15. Das P, Meyer L, Seyfert HM, Brockmann G, Schwerin M (1996) Structure of the growth hormone-encoding gene and its promoter in mice. Gene 169(2): 209-213.
16. O'Shea PJ, Bassett JH, Cheng SY, Williams GR (2006) Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: Implications for tissue thyroid status and T3 target gene expression. Nucl Recept Signal 4:e011.
17. Ying H, Araki O, Furuya F, Kato Y, Cheng SY (2007) Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Mol Cell Biol 27(6): 2359-2371.
18. Henry SL, et al. (2012) White adipocytes: More than just fat depots. Int J Biochem Cell Biol 44(3): 435-440.
19. Fozzatti L, Lu C, Kim DW, Cheng SY (2011) Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors. Mol Endocrinol 25(6): 908-921.
20. Gnaciñska M, Małgorzewicz S, Stojek M, Łysiak- Szydłowska W, Sworczak K (2009) Role of adipokines in complications related to obesity: A review. Adv Med Sci 54(2): 150-157.
21. Mishra A, Zhu XG, Ge K, Cheng SY (2010) Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms. J Mol Endocrinol 44(4): 247-255.
22. Menéndez-Hurtado A, Santos A, Pérez-Castillo A (2000) Characterization of the promoter region of the rat CCAAT/enhancer-binding protein alpha gene and regulation by thyroid hormone in rat immortalized brown adipocytes. Endocrinology 141(11): 4164-4170.
23. Esaki T, et al. (2003) Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. Endocrinology 144(9): 4117-4122.
24. Sarjeant K, Stephens JM (2012) Adipogenesis. Cold Spring Harb Perspect Biol 4(9): a008417.
25. Lonard DM, O'Malley BW (2012) Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat Rev Endocrinol 8(10): 598-604.
26. Furumoto H, et al. (2005) An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 25(1): 124-135.
27. Ying H, et al. (2003) Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis 24(9): 1467-1479.
28. Pérez-Mancera PA, et al. (2007) Adipose tissue mass is modulated by SLUG (SNAI2). Hum Mol Genet 16(23): 2972-2986.